Open-label Adjunctive Zonisamide for Bipolar Disorder
NCT00047567
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar Disorders
Interventions
DRUG:
zonisamide
Sponsor
Elan Pharmaceuticals